Epithelial Cell Transforming Sequence 2 Expression is Associated with the Progression of Laryngeal Squamous Cell Carcinoma

Overview

Journal Oncol Lett

Specialty Oncology

Date 2019 Jun 13

PMID 31186795

Citations 1

Authors

Lin Zhu

Gang Qin

Lin Ye

Li-Zhu Jiang

Tie-Jun Zhou

Bo Luo

Tao-Yu Wen

Ya-Lan Liu

Hong-Yan Chen

Affiliations

Soon will be listed here.

Abstract

Epithelial cell transforming sequence 2 (ECT2) is a guanine nucleotide exchange factor and its expression is associated with the development of malignant tumor types. However, to the best of our knowledge, there is no information on the role of ECT2 in the development and progression of laryngeal squamous cell carcinoma (LSCC). The present study aimed at investigating the expression pattern and potential role of ECT2 in the development and progression of LSCC. The expression of ECT2 in 81 pairs of LSCC and adjacent non-tumor tissues was characterized by immunohistochemistry and reverse transcription-quantitative polymerase chain reaction. ECT2 expression was upregulated in LSCC tissues and associated significantly with poor differentiation, higher stages, lymph node metastasis and poor survival in the sample population. The relative expression levels of ECT2 mRNA transcripts were correlated with the intensity of anti-ECT2 staining in 25 ECT2+LSCC specimens selected randomly. These results indicated that ECT2 expression was crucial for the progression of LSCC and may serve as a biomarker for the diagnosis and prognosis of LSCC.

Citing Articles

ECT2 promotes the occurrence and is a prognostic biomarker of head and neck squamous cell carcinoma.

Peng S, Wang J, Hei N, Cui Z J Cancer. 2024; 15(13):4156-4174.

PMID: 38947403 PMC: 11212090. DOI: 10.7150/jca.95515.

References

Tatsumoto T, Xie X, Blumenthal R, Okamoto I, Miki T . Human ECT2 is an exchange factor for Rho GTPases, phosphorylated in G2/M phases, and involved in cytokinesis. J Cell Biol. 1999; 147(5):921-8. PMC: 2169345. DOI: 10.1083/jcb.147.5.921. View

Vergote I, De Brabanter J, Fyles A, Bertelsen K, Einhorn N, Sevelda P . Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma. Lancet. 2001; 357(9251):176-82. DOI: 10.1016/S0140-6736(00)03590-X. View

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

Talamini R, Bosetti C, La Vecchia C, Dal Maso L, Levi F, Bidoli E . Combined effect of tobacco and alcohol on laryngeal cancer risk: a case-control study. Cancer Causes Control. 2003; 13(10):957-64. DOI: 10.1023/a:1021944123914. View

Saito S, Liu X, Kamijo K, Raziuddin R, Tatsumoto T, Okamoto I . Deregulation and mislocalization of the cytokinesis regulator ECT2 activate the Rho signaling pathways leading to malignant transformation. J Biol Chem. 2003; 279(8):7169-79. DOI: 10.1074/jbc.M306725200. View

Ramroth H, Dietz A, Becher H . Interaction effects and population-attributable risks for smoking and alcohol on laryngeal cancer and its subsites. A case-control study from Germany. Methods Inf Med. 2005; 43(5):499-504. View

Becher H, Ramroth H, Ahrens W, Risch A, Schmezer P, Dietz A . Occupation, exposure to polycyclic aromatic hydrocarbons and laryngeal cancer risk. Int J Cancer. 2005; 116(3):451-7. DOI: 10.1002/ijc.21049. View

Patel S, Shah J . TNM staging of cancers of the head and neck: striving for uniformity among diversity. CA Cancer J Clin. 2005; 55(4):242-58. DOI: 10.3322/canjclin.55.4.242. View

Yuce O, Piekny A, Glotzer M . An ECT2-centralspindlin complex regulates the localization and function of RhoA. J Cell Biol. 2005; 170(4):571-82. PMC: 2171506. DOI: 10.1083/jcb.200501097. View

10.

Scoumanne A, Chen X . The epithelial cell transforming sequence 2, a guanine nucleotide exchange factor for Rho GTPases, is repressed by p53 via protein methyltransferases and is required for G1-S transition. Cancer Res. 2006; 66(12):6271-9. DOI: 10.1158/0008-5472.CAN-06-0121. View

11.

Shangina O, Brennan P, Szeszenia-Dabrowska N, Mates D, Fabianova E, Fletcher T . Occupational exposure and laryngeal and hypopharyngeal cancer risk in central and eastern Europe. Am J Epidemiol. 2006; 164(4):367-75. DOI: 10.1093/aje/kwj208. View

12.

Sano M, Genkai N, Yajima N, Tsuchiya N, Homma J, Tanaka R . Expression level of ECT2 proto-oncogene correlates with prognosis in glioma patients. Oncol Rep. 2006; 16(5):1093-8. View

13.

Elston C, Ellis I . Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991; 19(5):403-10. DOI: 10.1111/j.1365-2559.1991.tb00229.x. View

14.

Ramroth H, Dietz A, Ahrens W, Becher H . Occupational wood dust exposure and the risk of laryngeal cancer: a population based case-control study in Germany. Am J Ind Med. 2008; 51(9):648-55. DOI: 10.1002/ajim.20605. View

15.

Justilien V, Fields A . Ect2 links the PKCiota-Par6alpha complex to Rac1 activation and cellular transformation. Oncogene. 2009; 28(41):3597-607. PMC: 2762483. DOI: 10.1038/onc.2009.217. View

16.

Justilien V, Jameison L, Der C, Rossman K, Fields A . Oncogenic activity of Ect2 is regulated through protein kinase C iota-mediated phosphorylation. J Biol Chem. 2010; 286(10):8149-8157. PMC: 3048701. DOI: 10.1074/jbc.M110.196113. View

17.

Rizzardi A, Johnson A, Vogel R, Pambuccian S, Henriksen J, Skubitz A . Quantitative comparison of immunohistochemical staining measured by digital image analysis versus pathologist visual scoring. Diagn Pathol. 2012; 7:42. PMC: 3379953. DOI: 10.1186/1746-1596-7-42. View

18.

Matthews H, Delabre U, Rohn J, Guck J, Kunda P, Baum B . Changes in Ect2 localization couple actomyosin-dependent cell shape changes to mitotic progression. Dev Cell. 2012; 23(2):371-83. PMC: 3763371. DOI: 10.1016/j.devcel.2012.06.003. View

19.

Cook D, Rossman K, Der C . Rho guanine nucleotide exchange factors: regulators of Rho GTPase activity in development and disease. Oncogene. 2013; 33(31):4021-35. PMC: 4875565. DOI: 10.1038/onc.2013.362. View

20.

Murata Y, Minami Y, Iwakawa R, Yokota J, Usui S, Tsuta K . ECT2 amplification and overexpression as a new prognostic biomarker for early-stage lung adenocarcinoma. Cancer Sci. 2014; 105(4):490-7. PMC: 4317802. DOI: 10.1111/cas.12363. View